Both in Biotechnology
Entera Bio vs Solid Biosciences
Over the past year ENTX returned +25.8% and SLDB returned +8.7%; their daily moves had a correlation of 0.14.
ENTX +25.8% SLDB +8.7%Growth of $1, one year, split-adjusted
| Metric | ENTX | SLDB |
|---|---|---|
| Price | $3.17 | $6.44 |
| Market cap | $551.3M | $690.0M |
| Today | +3.59% | +3.96% |
| 1 month | +17.8% | −10.1% |
| 6 months | +183.0% | −8.7% |
| Year to date | +63.4% | +14.1% |
| 1 year | +36.1% | +9.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $11.0M | $377.7M |
| Dividend yield | — | — |
| Volatility (60d) | 62.2% | 67.5% |
| Short % of float | 3.5% | 17.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).